CBS 2019
CBSMD教育中心
English

推荐文献

科研文章

荐读文献

Major infections after bypass surgery and stenting for multivessel coronary disease in the randomised SYNTAX trial State of the Art in Noninvasive Imaging of Ischemic Heart Disease and Coronary Microvascular Dysfunction in Women: Indications, Performance, and Limitations Treatment of higher-risk patients with an indication for revascularization: evolution within the field of contemporary percutaneous coronary intervention Efficacy and safety of rosuvastatin vs. atorvastatin in lowering LDL cholesterol : A meta-analysis of trials with East Asian populations Microthrombi As A Major Cause of Cardiac Injury in COVID-19: A Pathologic Study Optimal Stenting Technique for Complex Coronary Lesions Intracoronary Imaging-Guided Pre-Dilation, Stent Sizing, and Post-Dilation Radionuclide Image-Guided Repair of the Heart A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure 2-Year Outcomes After Stenting of Lipid-Rich and Nonrich Coronary Plaques
|<<... 13 14 15 16 17 18 19 ...>>|

Clinical Trial2019 Mar 18. [Epub ahead of print]

JOURNAL：N Engl J Med. Article Link

Coronary Angiography after Cardiac Arrest without ST-Segment Elevation

Lemkes JS, Janssens GN, van der Hoeven NW et al. Keywords: ischemic heart disease; out-of-hospital cardiac arrest; immediate coronary angiography; delayed angiography ; PCI; non STEMI; survival; 90 days

FULL TEXT PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top